Aad I. de Vos

Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.

Alex Sparreboom, Jaap Verweij, M.E.L. van der Burg et al. · PubMed · 1998 · 83 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry

Hans M. Westgeest, Carin A. Uyl‐de Groot, R. Jeroen A. van Moorselaar et al. · European Urology Focus · 2016 · 56 citations · Full text

Medicine, Oncology, Urology +14

Quantitation of Cremophor EL in Human Plasma Samples Using a Colorimetric Dye-Binding Microassay

Alex Sparreboom, Walter J. Loos, Jaap Verweij et al. · Analytical Biochemistry · 1998 · 55 citations

Natural Sciences, Chemistry, Pharmaceutical Analysis +4

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment

Anne‐Joy M. de Graan, Sebastiaan F. Teunissen, Filip De Vos et al. · Journal of Clinical Oncology · 2011 · 55 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study

Seyed M. Qaderi, J. Van Der Heijden, Rob H.A. Verhoeven et al. · European Journal of Cancer · 2021 · 54 citations · Full text

Pharmacy, Oncology, Cancer Symptom Management +16